Personal experience of eating adagrasib

Adagrasib (Adagrasib) is a KRAS inhibitor indicated for the treatment of locally advanced or metastatic KRAS G12C mutated non-small cell lung cancer in patients who have received at least one prior systemic therapy. Based on the results of clinical trials and studies, many patients have had positive feedback on adagrasib and experienced significant relief from their cancer. For example, some patients' tumors have shrunk and their symptoms have improved.

It has been reported that adagrasib shows high efficacy in the treatment of certain patients with non-small cell lung cancer. It is considered an innovative treatment method that can directly inhibit the growth of tumors caused by KRAS gene mutations. Compared with traditional chemotherapy, adagrasib may have less toxic side effects and provide better therapeutic effects. However, every patient's response may be different because each person's medical condition and disease profile are unique. While adagrasib can help relieve cancer symptoms, it does not completely cure the disease. Therefore, patients need to maintain a positive attitude towards life during treatment, continue to maintain good eating habits and moderate exercise to improve their quality of life.

Sinceadagrasibthe original drug has not yet been launched in China, patients can only purchase adagrasib through overseas channels, and the U.S. original version of 200mg*180 tablets is priced at hundreds of thousands of yuan per box (the price may fluctuate due to exchange rates), which is very expensive. Currently, there are no generic drugs of adagrasib produced overseas. For more drug information and specific prices, please consult Yaode’s medical consultant.